257 related articles for article (PubMed ID: 28851309)
1. Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.
Yamashita Y; Nishiumi S; Kono S; Takao S; Azuma T; Yoshida M
BMC Cancer; 2017 Aug; 17(1):589. PubMed ID: 28851309
[TBL] [Abstract][Full Text] [Related]
2. Glycoproteomic comparison of clinical triple-negative and luminal breast tumors.
Hill JJ; Tremblay TL; Fauteux F; Li J; Wang E; Aguilar-Mahecha A; Basik M; O'Connor-McCourt M
J Proteome Res; 2015 Mar; 14(3):1376-88. PubMed ID: 25658377
[TBL] [Abstract][Full Text] [Related]
3. Hyper-Elongation in Colorectal Cancer Tissue - Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies.
Mika A; Kobiela J; Czumaj A; Chmielewski M; Stepnowski P; Sledzinski T
Cell Physiol Biochem; 2017; 41(2):722-730. PubMed ID: 28214830
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.
Stewart DA; Winnike JH; McRitchie SL; Clark RF; Pathmasiri WW; Sumner SJ
J Proteome Res; 2016 Sep; 15(9):3225-40. PubMed ID: 27447733
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.
Kanaan YM; Sampey BP; Beyene D; Esnakula AK; Naab TJ; Ricks-Santi LJ; Dasi S; Day A; Blackman KW; Frederick W; Copeland RL; Gabrielson E; Dewitty RL
Cancer Genomics Proteomics; 2014; 11(6):279-94. PubMed ID: 25422359
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characterization of triple negative breast cancer.
Cao MD; Lamichhane S; Lundgren S; Bofin A; Fjøsne H; Giskeødegård GF; Bathen TF
BMC Cancer; 2014 Dec; 14():941. PubMed ID: 25495193
[TBL] [Abstract][Full Text] [Related]
7. Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer.
Hashimoto Y; Tatsumi S; Takeda R; Naka A; Ogane N; Kameda Y; Kawachi K; Shimizu S; Sakai M; Kamoshida S
Breast Cancer Res Treat; 2014 May; 145(1):101-11. PubMed ID: 24671357
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Downregulates ELOVL1 Gene Expression and Fatty Acid Synthesis in Goat Fetal Fibroblasts.
Wang W; He Q; Guo Z; Yang L; Bao L; Bao W; Zheng X; Wang Y; Wang Z
Int J Mol Sci; 2015 Jul; 16(7):16440-53. PubMed ID: 26204830
[TBL] [Abstract][Full Text] [Related]
9. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of HER2-positive and triple-negative status in small (≤ 1 cm) node-negative breast cancer.
Gorshein E; Klein P; Boolbol SK; Shao T
Clin Breast Cancer; 2014 Oct; 14(5):309-14. PubMed ID: 24703318
[TBL] [Abstract][Full Text] [Related]
11. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
[TBL] [Abstract][Full Text] [Related]
12. Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.
Rao D; Kimler BF; Nothnick WB; Davis MK; Fan F; Tawfik O
Hum Pathol; 2015 Jun; 46(6):876-83. PubMed ID: 25841305
[TBL] [Abstract][Full Text] [Related]
13. Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
Pacheco-Velázquez SC; Gallardo-Pérez JC; Aguilar-Ponce JL; Villarreal P; Ruiz-Godoy L; Pérez-Sánchez M; Marín-Hernández A; Ruiz-García E; Meneses-García A; Moreno-Sánchez R; Rodríguez-Enríquez S
Int J Oncol; 2014 Dec; 45(6):2549-59. PubMed ID: 25270118
[TBL] [Abstract][Full Text] [Related]
14. Potential prognostic tumor biomarkers in triple-negative breast carcinoma.
Peng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):666-72. PubMed ID: 23073572
[TBL] [Abstract][Full Text] [Related]
15. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.
Purrington KS; Visscher DW; Wang C; Yannoukakos D; Hamann U; Nevanlinna H; Cox A; Giles GG; Eckel-Passow JE; Lakis S; Kotoula V; Fountzilas G; Kabisch M; Rüdiger T; Heikkilä P; Blomqvist C; Cross SS; Southey MC; Olson JE; Gilbert J; Deming-Halverson S; Kosma VM; Clarke C; Scott R; Jones JL; Zheng W; Mannermaa A; ; Eccles DM; Vachon CM; Couch FJ
Breast Cancer Res Treat; 2016 May; 157(1):117-31. PubMed ID: 27083182
[TBL] [Abstract][Full Text] [Related]
16. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
18. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of fatty acid elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased fatty acid oxidation.
Jakobsson A; Jörgensen JA; Jacobsson A
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E517-26. PubMed ID: 15855229
[TBL] [Abstract][Full Text] [Related]
20. The fatty acid chain elongase, Elovl1, is required for kidney and swim bladder development during zebrafish embryogenesis.
Bhandari S; Lee JN; Kim YI; Nam IK; Kim SJ; Kim SJ; Kwak S; Oh GS; Kim HJ; Yoo HJ; So HS; Choe SK; Park R
Organogenesis; 2016 Apr; 12(2):78-93. PubMed ID: 27078170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
